对丁胆酶的新见解:制药应用,选择性抑制剂和多目标导向配体
Tianyu Sun1, Tengfei Zhen1, Chrisanta Hamis Harakandi1
1School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.
European journal of medicinal chemistry
|June 9, 2024
概括
乙基胆酶 (BChE) 在阿尔茨海默病和脂质代谢中发挥作用. 新的抑制剂和调节剂在治疗认知障碍和代谢疾病方面表现有前途.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙胆酶 (BChE) 是一种酶,参与乙胆的降解,特别是在病理条件下.
- 已知BChE在治疗阿尔茨海默病 (AD),多发性硬化症和有机中毒方面的应用.
- 新兴研究将BChE与脂质代谢联系起来,包括 ghrelin 水解和低密度脂蛋白 (LDL) 调节.
研究的目的:
- 总结最近在选择性BChE抑制剂和与BChE相关的多目标导向配体方面的进展.
- 审查BCh.E.目前的药理学应用.
- 探索针对AD和脂质代谢障碍的BCHE的新型治疗策略.
主要方法:
- 在过去三年中发表的选择性BCHE抑制剂和BCHE相关的多目标导向配体的文献综述.
- 对研究BCHE在阿尔茨海默氏症病原和进展中的作用的研究分析.
- 对BChE参与脂质代谢途径的研究进行审查.
主要成果:
- 在阿尔茨海默病的晚期阶段,BCHE水平会增加,BCHE抑制剂在动物模型中显示出缓解认知缺陷的潜力.
- 新型BChE抑制剂和多目标导向的配体正在开发中,包括独特的调节剂,将BChE和素脱乙酶标结合起来,用于AD.
- BChE通过解格林来影响脂质代谢,抑制LDL吸收,并降低LDL受体表达的调节.
结论:
- BChE是阿尔茨海默病的有希望的治疗标,抑制剂显示出潜在的认知益处.
- BChE在脂质代谢中的作用为治疗代谢障碍的治疗干预提供了新的途径.
- 对BCHE调节器及其联合向策略的进一步研究具有显著的治疗潜力.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.0K
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
相关概念视频
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
554
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
554
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:22Cholinesterases: Distribution and Function
452
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
452
00:49Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
01:28Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699